Results 41 to 50 of about 39,409 (160)

Prevalence and factors associated with the intention to vaccinate against COVID-19 in Peru

Revista Peruana de Medicina Experimental y Salud Pública, 2021
Objectives: To estimate the prevalence and factors associated with COVID-19 vaccination intention (VI) in Peru. Materials and methods: Analytical cross-sectional study using the survey conducted by the University of Maryland, USA, on Facebook.
Percy Herrera-Añazco, Ángela Uyen-Cateriano, Diego Urrunaga-Pastor, Guido Bendezu-Quispe, Carlos J. Toro-Huamanchumo, Alfonso J. RodrÍguez-Morales, Adrian V. Hernández, Vicente A. Benites-Zapata   +7 more
doaj   +1 more source

Transiciones entre los estados de diagnóstico de personas con la COVID-19 en Colombia

Revista Panamericana de Salud Pública, 2020
Objetivo. Determinar las probabilidades de transición entre distintos tipos de atención y estados para la población infectada con la COVID-19 en Colombia, por grupos de edad. Métodos.
Luis Carlos Manrique Ruiz, Guberney Muñetón Santa, Osmar Leandro Loaiza Quintero   +2 more
doaj   +1 more source

Contribución de la investigación en enfermería a la lucha contra la pandemia de COVID-19. Una revisión sistemática

Revista Cuidarte, 2022
Introducción: La pandemia de la enfermedad de coronavirus 2019 (COVID-19), debería ser una oportunidad para asegurar una mayor visibilidad de la enfermería en los sistemas de salud y la sociedad en todo el mundo.
Lyda Rojas, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, Sandra Lucrecia Romero Guevara   +3 more
doaj   +1 more source

Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan [PDF]

Journal of Pathology and Translational Medicine, 2023
Background Coronavirus disease 2019 (COVID-19) has emerged as a pandemic for more than 2 years. Autopsy examination is an invaluable tool to understand the pathogenesis of emerging infections and their consequent mortalities. The aim of the current study
Maram Abdaljaleel, Isra Tawalbeh, Malik Sallam, Amjad Bani Hani, Imad M. Al-Abdallat, Baheth Al Omari, Sahar Al-Mustafa, Hasan Abder-Rahman, Adnan Said Abbas, Mahmoud Zureigat, Mousa A. Al-Abbadi   +10 more
doaj   +1 more source

Recomendaciones para la comunicación de malas noticias por teléfono durante la pandemia por SARS-CoV-2

Revista Panamericana de Salud Pública, 2020
La pandemia actual por SARS-CoV-2 presenta desafíos específicos para los profesionales de salud en el campo de la atención sanitaria. En este contexto de emergencia, la comunicación de malas noticias toma especial relevancia por el modo particular en que
Laura F. Belli
doaj   +1 more source

Canine coronaviruses: emerging and re-emerging pathogens of dogs

Berliner und Münchener Tierärztliche Wochenschrift, 2021
Canine coronavirus (CCoV) and canine respiratory coronavirus (CRCoV) are highly infectious viruses of dogs classified as Alphacoronavirus and Betacoronavirus, respectively.
Ahmed Abd El Wahed, Uwe Truyen
doaj   +1 more source

Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus [PDF]

, 2013
A novel betacoronavirus associated with lethal respiratory and renal complications was recently identified in patients from several countries in the Middle East.
Pybus, OG, Guan, Y, Matthew Cotten, Lam, TY, Pybus, Oliver G, Paul Kellam, Palser, Anne L., Guan, Yi, Petrova, V, Nastouli, Eleni, Anne L. Palser, Rambaut, A, Palser, Anne L, Pillay, Deenan, Cotten, M, Cotten, Matthew, Lam, TT, Eleni Nastouli, Lam, Tommy T, Simon J. Watson, Paul Grant, Petrova, Velislava, Watson, Simon J., Grant, P, Velislava Petrova, Palser, AL, Pillay, D, Rambaut, Andrew, Watson, Simon J, Pybus, Oliver G., Kellam, P, Andrew Rambaut, Pybus, Oliver, Tommy T. Lam, Kellam, Paul, Watson, SJ, Oliver G. Pybus, Yi Guan, Lam, Tommy T., Grant, Paul, Deenan Pillay, Nastouli, E   +41 more
core   +1 more source

Pathological and Biochemical Alteration in COVID-19

Assam Journal of Internal Medicine, 2021
Corona virus disease 2019 (COVID-19) caused by severe acute respiratory corona virus 2 (SARS-COV-2) is mainly respiratory disease occurring since December 2019 and first detected in Wuhan province of China.
Noni Gopal Singha
doaj   +1 more source

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape

Frontiers in Immunology, 2023
IntroductionConsidering the likely need for the development of novel effective vaccines adapted to emerging relevant CoV-2 variants, the increasing knowledge of epitope recognition profile among convalescents and afterwards vaccinated with identification
Jamille Ramos Oliveira, Jamille Ramos Oliveira, Jamille Ramos Oliveira, Cesar Manuel Remuzgo Ruiz, Rafael Rahal Guaragna Machado, Jhosiene Yukari Magawa, Jhosiene Yukari Magawa, Jhosiene Yukari Magawa, Isabela Pazotti Daher, Isabela Pazotti Daher, Isabela Pazotti Daher, Alysson Henrique Urbanski, Gabriela Justamante Händel Schmitz, Gabriela Justamante Händel Schmitz, Helen Andrade Arcuri, Marcelo Alves Ferreira, Greyce Luri Sasahara, Giuliana Xavier de Medeiros, Roberto Carlos Vieira Silva Júnior, Edison Luiz Durigon, Edison Luiz Durigon, Silvia Beatriz Boscardin, Daniela Santoro Rosa, Daniela Santoro Rosa, Deborah Schechtman, Helder I. Nakaya, Helder I. Nakaya, Edecio Cunha-Neto, Edecio Cunha-Neto, Edecio Cunha-Neto, Gabriele Gadermaier, Jorge Kalil, Jorge Kalil, Jorge Kalil, Verônica Coelho, Verônica Coelho, Verônica Coelho, Keity Souza Santos, Keity Souza Santos, Keity Souza Santos   +39 more
doaj   +1 more source

Cross-Reactive IgG Antibody Responses to SARS-CoV-2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015-2017). [PDF]

Influenza Other Respir Viruses
ABSTRACT The extent of cross‐reactive antibodies to SARS‐CoV‐2 elicited by seasonal human coronaviruses (HCoVs) remains unclear. We analyzed longitudinal preinfection and postinfection IgG responses in 62 older adults with PCR‐confirmed HCoV infections from sera collected prior to the emergence of SARS‐CoV‐2.
Xiao C, Leung NHL, Ling S, Lin X, Chen Y, Xie Y, Peiris M, Zanin M, Cowling B, Wong SS.   +9 more
europepmc   +2 more sources